Effectiveness and Safety of Fluticasone Propionate in Adolescents and Adults Who Have Asthma

Study Title
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Teva Identifier
FpS-AS-201 | 2010-023600-27
ClinicalTrials.gov Identifier
NCT01479621
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Fp MDPI | Drug: Flovent Diskus | Drug: albuterol/salbutamol | Drug: Placebo MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
01/01/2012 - 07/01/2013
Phase
Phase 2

Study Type

Interventional